ClinicalTrials.Veeva

Menu

Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level

S

Superior University

Status

Active, not recruiting

Conditions

Papillary Thyroid Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT07062211
MSAHSW/Batch-Fall23/908

Details and patient eligibility

About

This research will employ cross-sectional analytical to determine diagnostic accuracy of Flourodeoxyglucose-18 Positron Emission Computed Tomography in the evaluation of Recurrent Papillary Thyroid Carcinoma with patient's raised Thyroglobulin level in Lahore.

Enrollment

39 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients include both male and female from 18years to 80years
  • Patients presented with raised thyroglobulin
  • Patients with suspected diagnosis of recurrent papillary thyroid carcinoma

Exclusion criteria

  • Patients exclude both male and female below 18years and above 80years
  • All the patients presented with carcinoma other than papillary carcinoma.
  • All the patients with normal thyroglobulin level.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems